Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,564 | 2,816 | 4,615 | 3,673 | 6,835 |
| Receivables | 8,868 | 8,260 | 8,339 | 8,316 | 5,423 |
| Inventories | 3,782 | 3,699 | 3,638 | 3,975 | 4,079 |
| TOTAL | $15,735 | $16,202 | $17,658 | $16,999 | $17,482 |
| Non-Current Assets | |||||
| PPE Net | 2,801 | 2,973 | 2,798 | 2,119 | 2,127 |
| Intangibles | 290 | 375 | 257 | 246 | 273 |
| Other Non-Current Assets | 4,697 | 4,522 | 4,297 | 4,565 | 4,175 |
| TOTAL | $7,788 | $7,870 | $7,352 | $6,930 | $6,575 |
| Total Assets | $23,522 | $24,072 | $25,010 | $23,929 | $24,057 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,718 | 4,390 | 4,946 | 3,819 | 3,796 |
| TOTAL | $4,914 | $4,886 | $5,286 | $3,819 | $3,796 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 196 | 496 | 340 | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,914 | $4,886 | $5,286 | $3,819 | $3,796 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,628 | 9,628 | 9,627 | 9,611 | 9,611 |
| Common Shares | 96 | 96 | 96 | 96 | 96 |
| Retained earnings | -29,239 | -28,575 | -27,928 | -27,433 | -27,162 |
| TOTAL | $18,609 | $19,187 | $19,724 | $20,109 | $20,261 |
| Total Liabilities And Equity | $23,522 | $24,072 | $25,010 | $23,929 | $24,057 |